24

2026

-

06

Microread Genetics Make your debut at the ESHG 2026 European Society of Human Genetics Conference!


The 2026 European Society of Human Genetics Conference (ESHG) concluded successfully in Gothenburg. Microread Genetics showcased its two core product lines, namely tumor precision diagnosis and reproductive genetics, attracting numerous international colleagues to stop by and exchange ideas. The atmosphere at the event was extremely lively.

In the oncology field, we have highlighted the microsatellite instability (MSI), POLE mutation sequencing, and KRAS/NRAS/BRAF/PIK3CA combined test kits. We have also developed an overall classification scheme for endometrial cancer (MMR + MSI + POLE + TP53) and colorectal cancer, which precisely aligns with authoritative guidelines such as NCCN, ESMO, and CSCO. In the reproductive genetics direction, the FMR1 gene CGG repeat detection, chromosome aneuploidy (T21/T18/T13/X/Y) detection, and pre-pregnancy carrier screening combination have received extensive attention. These have gained recognition through dual CE and NMPA certifications, along with the excellent performance and features of the product.

 

Based on 17 years of experience in capillary electrophoresis (CE) technology, as well as the "reagents + instruments + software" integrated solution, we have received high recognition from channel partners, molecular diagnostic laboratories and research forensic institutions in European countries such as the Czech Republic, Turkey, Sweden, Italy and Spain, as well as in North Africa and the Middle East. We have also engaged in in-depth discussions on regional cooperation with multiple parties. Although the exhibition has come to an end, the cooperation journey has just begun.

 

Microread Genetics is willing to collaborate with global partners, using the gold standard of precision to convey complete clinical confidence, and jointly promote precision medicine to a broader stage!